A small, hand-held microscope could make it easier to noninvasively spot seed cells that can travel through the blood stream and create new tumors.
Currently, doctors draw a patient’s blood and analyze it using special antibodies to detect the presence of the seeds, called circulating tumor cells (CTCs). This works well if CTCs are present in large numbers, but may fail to detect smaller numbers released by earlier tumors.
Now, a team of engineers, scientists, and doctors from Stanford University is developing a mini-microscope that might be able to noninvasively detect the CTCs earlier than ever, allowing for earlier interventions.
“There has been a huge push to increase sensitivity,” says Bonnie King, an instructor at Stanford School of Medicine. “We suspect that CTCs often circulate in numbers below our current threshold of detectability.”
A major advantage with the microscopic technique, King says, is the ability to screen much larger volumes of blood, rather than just a small vial collected from a patient. This will be done using a method called in vivo flow cytometry—a laser-based technology for counting cells in a live subject.
Christopher Contag, a professor of pediatrics at the School of Medicine, envisions that a doctor would inject a patient with a dye that will cause the CTCs to fluoresce. The doctor would then use the pen-size microscope to focus a low-power laser light on a blood vessel just a few hair-widths below the patient’s skin.
As the dyed cancer cells pass through the laser, the light excites them and causes them to stand out from normal cells. The microscope registers each of these cells and a computer logs each observation.
The improved sensitivity of the technology and the ability to noninvasively scan blood for long periods will help create a fuller picture of the number of CTCs in a person’s body.
“At present we will not screen all of a person’s blood [with the microscope], but we are aiming to increase the amount of blood screened compared to a 7-milliliter blood draw,” Contag explains.
To date, the group has focused on developing the method in mice, taking advantage of the thin transparent tissue of the ear to image fluorescent cells traversing the small blood vessels below the skin.
Soon the researchers will move the microscope to a clinical setting to conduct a proof-of-principle test of the technique in humans.
Team member Geoffrey Gurtner, a professor of surgery, is currently conducting a clinical trial to evaluate the FDA-approved green dye for defining skin vasculature during post-mastectomy breast reconstruction surgeries. The researchers are piggybacking on this trial to test the miniature microscope’s ability to detect blood vessels and circulating cells.
Source: Stanford University